Navigation Links
THE PLANNING SHOP international Announces Oncology Business Unit
Date:6/30/2010

PHILADELPHIA and LONDON, June 30 /PRNewswire/ -- THE PLANNING SHOP international (TPSi) is pleased to announce the launch of its new Oncology Business Unit (OBU) which will be fully dedicated to the oncology therapeutic area. This announcement was made at the European Pharmaceutical Market Research Association (EphMRA) Conference, which was held June 22-24, 2010, in Berlin, Germany.

Oncology is a complex, fast moving therapeutic area.  Numerous pharmaceutical products are currently approved or under development for the treatment of more than 200 different types of cancer.  Conducting oncology market research is challenging because it is difficult to find a marketing research agency that truly understands the therapeutic area as well as the brand implications of various investigational and marketed pharmaceutical products.  The TPSi OBU consists of a team that is fully dedicated to oncology projects and is led by market research professionals who are experts in both the therapeutic area and the relevant associated brands. Leading the OBU is Kelly Price, who has spent eight years working in both syndicated and customized oncology research in Japan, China, throughout Asia Pacific, and most recently in the United States.

"TPSi is delighted to welcome Kelly Price to head up its new Oncology Business Unit," said Kim Hughes, Managing Director, TPSi London.  "Her joining TPSi represents the merger of deep oncology therapy knowledge with broad brand understanding, the synergies of which will provide clients with brand strategy for a fast-shifting clinical context."

The TPSi Oncology Business Unit was established when the company recognized that most of its clients were increasingly involved in oncology -- either marketing existing compounds or developing new compounds.  According to Sherry Fox, President, TPSi North America and founder of the unit, "We recognized the need for a dedicated division focused on oncology, so we set out to find a leader who  would contribute the necessary expertise.  Many of our clients are specifically asking for this level of oncology knowledge, which combined with our brand strategy experience will provide a complete solution to oncology marketing research needs."  

About THE PLANNING SHOP international

THE PLANNING SHOP international was established in 1987 as a strategic brand consultancy.  The company quickly expanded into market research and the pharmaceutical industry in particular, on which it now focuses 100% of its efforts.  The organization's unique brand-building market research products, delivered through branding and consultancy experience, makes TPSi unique in the pharmaceutical market research sector.  Constantly innovating by using new techniques, TPSi is committed to helping its clients build superior brands from Phase 2 to in-market.  With offices in London, Brussels, and Philadelphia, TPSi focuses on brand strategy in addition to market research, working on behalf of clients around the globe.  


'/>"/>
SOURCE THE PLANNING SHOP international
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
2. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
3. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
4. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
5. Centage Corporation Announces Planning Maestro Business Performance Management Software for Mid-Market Enterprises
6. Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
7. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
8. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
9. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
10. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
11. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... A leader in science-based, ... , Nerium International is proud to introduce its Age-Defying Night Cream, NeriumAD™ Formula, ... to consumers across Hong Kong. The luxury skincare products contain innovative ingredients that ...
(Date:2/17/2017)... ... ... Academy of Model Aeronautics (AMA), the nation’s leading voice ... systems (UAS), are launching a joint program to promote safe and responsible drone ... efforts. , AMA and DJI will collaborate on other potential opportunities to mutually ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... Feb. 16, 2017   Biostage, Inc. (Nasdaq: ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, announced today the closing on February 15, 2017 ... of common stock and warrants to purchase 20,000,000 shares ... million. The offering was priced at $0.40 per share ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017  EyeLock LLC, a market leader of ... paper " What You Should Know About Biometrics in ... user authenticity is a growing concern. In traditional schemes, ... However, traditional authentication schemes such as username/password suffer from ... authentication offers an elegant solution to the problem of ...
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... growing genetic information companies, today announced that it will ... and provide 2017 guidance on Monday, February 13, 2017, ... that day at 4:45 p.m. Eastern / 1:45 p.m. ... team will briefly review financial results, guidance, and recent ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
Breaking Biology News(10 mins):